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Abstract  23 
Alternative microbial hosts have been engineered as biocatalysts for butanol biosynthesis. 24 
The butanol synthetic pathway of Clostridium acetobutylicum was first re-constructed in 25 
Escherichia coli to establish a baseline for comparison to other hosts.  Whereas 26 
polycistronic expression of the pathway genes resulted in the production of 34 mg/L 27 
butanol, individual expression of pathway genes elevated titers to 200 mg/L.  Improved 28 
titers were achieved by co-expression of Saccharomyces cerevisiae formate 29 
dehydrogenase while overexpression of E. coli glyceraldehyde 3-phosphate 30 
dehydrogenase to elevate glycolytic flux improved titers to 580 mg/L.  Pseudomonas 31 
putida and Bacillus subtilis were also explored as alternative production hosts. 32 
Polycistronic expression of butanol biosynthetic genes yielded butanol titers of 120 mg/L 33 
and 24 mg/L from P. putida and B. subtilis, respectively.  Production in the obligate 34 
aerobe P. putida was dependent upon expression of bcd-etfAB.  These results demonstrate 35 
the potential of engineering butanol biosynthesis in a variety of heterologous 36 
microorganisms, including those cultivated aerobically.    37 
 38 
Keywords: biofuel, butanol, E. coli, P. putida, B. subtilis, tolerance, product inhibition. 39 
40 
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Introduction 41 
With applications as a feedstock in plastic manufacturing and as an industrial 42 
solvent, the current butanol market in the United States alone is about 2.9 billion lbs per 43 
annum. However, chemical synthesis of butanol relies upon propylene feedstock, a 44 
petroleum-based substrate (Ezeji et al., 2007). Alternatively, butanol (biobutanol) can be 45 
naturally synthesized by solventogenic bacteria of the genus Clostridium through 46 
fermentation of renewable substrates, such as glucose.  The once prosperous Acetone-47 
Butanol-Ethanol (ABE) fermentation has garnered resurgent interest as a result of 48 
unprecedented economic and political concerns associated with increasing demand of 49 
nonrenewable energy resources.  In this regard, biobutanol has also emerged as a 50 
promising renewable liquid transportation fuel. With thermodynamic and physical 51 
properties that are highly akin to those of gasoline, biobutanol can be used either as a 52 
blending agent or direct fuel replacement in conventional vehicles (Antoni et al., 2007). 53 
More specifically, butanol possesses a nearly 50% higher energy density than ethanol, 54 
representing about 95% of the energy density of gasoline (Cascone, 2008). Since it is 55 
nearly 12-times more hydrophobic than ethanol, butanol can also be distributed and 56 
utilized within existing transportation fuel infrastructures without corrosive consequences.  57 
The suitability of Clostridial biocatalysts for use in industrial fermentations 58 
suffers from several phenotypic disadvantages, including spore formation that can result 59 
in the loss of butanol forming abilities. Additionally, stresses caused by butanol toxicity 60 
have been attributed to the loss of pSOL1, a mega-plasmid encoding several essential 61 
solvent-forming genes (Borden and Papoutsakis, 2007).  Furthermore, the metabolic shift 62 
from acidogenesis to solventogenesis in Clostridium presents additional complications 63 
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for continuous culture (Antoni et al., 2007). Overall, despite efforts to improve the 64 
biobutanol production efficiency of Clostridium (Harris et al., 2000; Mermelstein et al., 65 
1994; Sillers et al., 2008; Tomas et al., 2003), relatively poor characterization and a lack 66 
of compatible genetic tools remain as central obstacles impeding natural biocatalyst 67 
progression.   68 
In addition to phenotypic instabilities associated with Clostridial biocatalysts, the 69 
productivity of butanol fermentations is routinely limited by the effects of product 70 
cytotoxicity. Butanol has been found to accumulate primarily within the cytoplasmic 71 
membrane of Clostridium (Bowles and Ellefson, 1985) where it leads to disruption of the 72 
ordered structure of the phospholipid bilayer. This phenomenon produces an increase in 73 
membrane fluidity (Osborne et al., 1990b) which results in the loss of intracellular 74 
molecules (including proteins, RNA, and ATP), as well as an inability to maintain 75 
transmembrane ion gradients (Isken and de Bont, 1998). The resultant feed-back 76 
inhibition precludes butanol accumulation in culture media to titers above ~13 g/L for 77 
wild-type strains (Jones and Woods, 1986).   78 
In C. acetobutylicum, butanol biosynthesis begins with the condensation of two 79 
molecules of acetyl-CoA to yield acetoacetyl-CoA. This reaction is catalyzed by a 80 
thiolase which is encoded by thil (Figure 1). The genes encoding for enzyme activities for 81 
the step-wise conversion of acetoacetyl-CoA to butyryl-CoA are clustered together in the 82 
polycistronic BCS operon. This operon is comprised of the genes crt, bcd, etfAB, and hbd, 83 
encoding for crotonase, butyryl-CoA dehydrogenase, electron transfer proteins, and 3-84 
hydroxybutyryl-CoA dehydrogenase, respectively. A bi-functional aldehyde/alcohol 85 
dehydrogenase, encoded by either adhE1 or adhE2, catalyzes the final steps of butanol 86 
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synthesis from butyryl-CoA (Figure 1). Although C. acetobutylicum adhE1 can catalyze 87 
the conversion of butyryl-CoA to butyraldehyde and then butanol with a single enzyme, it 88 
can also mediate the synthesis of ethanol from acetyl-CoA (through acetaldehyde). C. 89 
acetobutylicum also possesses two distinct butanol dehydrogenase isozymes, encoded by 90 
bdhA and bdhB which have been found to have a high specificity for the conversion of 91 
butyraldehyde to butanol (Welch et al., 1989). In that same study, it was also reported 92 
that bdhB provided a significantly higher catalytic turn over rate of butyraldehyde than 93 
bdhA. Recently, different groups have successfully re-constructed the butanol 94 
biosynthetic pathway of C. acetobutylicum using heterologous microorganisms, including 95 
E. coli (Atsumi et al., 2008a; Inui et al., 2008) and S. cerevisiae (Steen et al., 2008).  96 
Although S. cerevisiae has been found to possess favorable industrial attributes, including 97 
moderate butanol tolerance (Fischer et al., 2008; Knoshaug and Zhang, 2008), 98 
preliminary attempts to engineer butanol biosynthesis in yeast have resulted in the 99 
production of merely 2.5 mg/L (Steen et al., 2008).  Meanwhile, butanol titers in E. coli 100 
engineered to express the Clostridium butanol pathway have been reported as high as 552 101 
mg/L (Atsumi et al., 2008a).  The biosynthesis of butanol, as well as other higher 102 
alcohols of interest, from keto-acid precursors (typically used in amino acid biosynthesis) 103 
has also been explored as an alternative route towards biofuel production (Atsumi et al., 104 
2008b). In subsequent studies it was shown that through this non-natural pathway, 105 
butanol could be produced in excess of 800 mg/L as a co-product with n-propanol (Shen 106 
and Liao, 2008).  Although the effects of product inhibition were likely to have remained 107 
unnoticed given the relatively low titers achieved in each of these previous studies, the 108 
butanol toxicity threshold of E. coli is known to be below that of Clostridium (Fischer et 109 
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al., 2008; Knoshaug and Zhang, 2008).  Thus, it is anticipated that modest inhibitory 110 
thresholds of these strains will ultimately limit their achievable outputs as their 111 
productivity is further engineered to that which is required of production-level strains. 112 
Solvent tolerant phenotypes consist of evolved mechanisms by which many 113 
opportunistic microorganisms have developed the means to survive in extreme 114 
environments.  Notable naturally solvent tolerant bacteria include species of 115 
Rhodococcus, Bacillus, and Pseudomonas (de Bont, 1998).  For example, P. putida S12 116 
derives its solvent tolerance from an increased proportion of trans-unsaturated fatty acids 117 
in its cytoplasmic membrane (Heipieper and Debont, 1994), as well as through the use of 118 
active efflux pump systems.  Such mechanisms permit maintenance of cytoplasmic 119 
membrane integrity in the presence of high concentrations of organic solvents, and have 120 
allowed P. putida S12 to demonstrate moderate tolerance to butanol in previous studies 121 
(de Carvalho et al., 2004).  For these same reasons, P. putida S12 has also previously 122 
been employed as an engineered host strain for the biosynthesis of phenol (Wierckx et al., 123 
2005) and cinnamic acid (Nijkamp et al., 2005).  Meanwhile, solvent tolerant species of 124 
Bacillus have also been isolated that can tolerate butanol concentrations as high as 2.5-125 
3.7% (wt./vol.) (Sardessai and Bhosle, 2002), by incorporating tolerance mechanisms that 126 
can include adaptations to the cell wall composition and through the use of stress 127 
response proteins (Kang et al., 2007).  In an effort to explore an alternative paradigm 128 
towards the engineering of robust biocatalysts, we have re-constructed the butanol 129 
biosynthesis pathway in heterologous hosts with known natural solvent tolerance and 130 
high industrial utility (Schmid et al., 2001).  More specifically, we have engineered 131 
functional pathway expression strategies to allow biobutanol synthesis by both 132 
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Pseudomonas putida and Bacillus subtilis.  To provide a baseline for comparison, our 133 
study begins by also engineering butanol biosynthesis in E. coli.  In contrast to previous 134 
works, we apply alternative strategies for functional pathway construction and continue 135 
on to explore the effects of the overexpression of enzymes involved in increasing 136 
glycolytic flux or regenerating NADH on butanol production. 137 
 138 
Materials and Methods 139 
Microbial strains 140 
 C. acetobutylicum ATCC 824 and P. putida S12 were purchased from the 141 
American Type Culture Collection (ATCC, Manassas, VA).  B. subtilis KS438, a 142 
sporulation deficient strain, was kindly provided by Dr. Alan Grossman of the 143 
Department of Biology at the Massachusetts Institute of Technology, USA.  E. coli 144 
DH10B and XL1-Blue (Stratagene, La Jolla, CA) were used for cloning and plasmid 145 
maintenance. E. coli BL21Star(DE3) (Invitrogen, Carlsbad, CA) was used as the host 146 
strain to allow the expression of genes under the T7lac promoter. 147 
 148 
Plasmid construction 149 
Genes derived from C. acetobutylicum ATCC 824 (thil, hbd, crt, bcd, etfAB, 150 
adhE1, adhE2), E. coli K-12 (atoB and gapA), and P. putida KT2440 (acd) were 151 
obtained via polymerase chain reaction (PCR) using genomic DNA (gDNA) templates. 152 
All gDNA samples were prepared using the Wizard Genomic DNA Purification Kit 153 
(Promega, Madison, WI). S. cerevisiae fdh1 chromosomal DNA (cDNA) fragment was 154 
obtained from mRNA using SuperScript One-Step RT-PCR (Invitrogen, Carlsbad, CA). 155 
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RNA was isolated from S. cerevisiae grown overnight in YPD medium (Difco, Franklin 156 
Lakes, NJ). Custom oligonucleotides (primers) were purchased for all PCR 157 
amplifications (Sigma-Genosys, St. Louis, MO).  158 
The natural butanol biosynthesis pathway of C. acetobutylicum (Figure 1) was 159 
first re-constructed using two broad host range compatible expression vectors, 160 
pMMB206G and pRK415 ((Keen et al., 1988a); kindly donated by Dr. Keith Poole, 161 
Department of Microbiology and Immunology, Queen’s University, Canada), which 162 
possess the RSF1010 and RK2 replicons, respectively.  pMMB206G contains a taclac 163 
(tac-lacUV5 in tandem) promoter and a gentamycin resistance selective marker while 164 
pRK415 contains a lac promoter and a tetracyclin resistance marker.  pMMB206G was 165 
constructed by ligating the Klenow-filled, MluI-MluI gentamycin resistance cassette from 166 
pBSL141 (ATCC; (Alexeyev et al., 1995)) into the XmnI site of pMMB206 (ATCC; 167 
(Morales et al., 1991)), thereby disrupting the original chloramphenicol resistance marker.  168 
To construct pmT, thil was first ligated into the BamHI site of pMMB206G.  pmTA1 was 169 
then generated by ligation of adhE1 between the SalI – PstI sites of pmT.  bdhB was then 170 
ligated into the SalI site of pmTA1 to yield pmTBA1.  prBCS was constructed by 171 
inserting the 4.7-kb BCS operon (containing crt, bcd, etfAB, and hbd) into the BamHI site 172 
of pRK415.  To investigate the effects of background butyryl-CoA dehydrogenase 173 
activity in P. putida strains, prCCS was constructed by first digesting prBCS with ApaLI 174 
and DraIII.  The linearized, 14.4 kb fragment was gel purified then Klenow-filled to 175 
generate a blunt-end product.  This truncated fragment was then re-ligated with itself to 176 
create prCCS (a bcd
 _
 and etfB
 _
 derivative of prBCS). 177 
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Compatible vectors pETDuet-1, pCDFDuet-1, pACYCDuet-1, and pCOLADuet-178 
1 (Novagen, Darmstadt, Germany) were used to provide individual expression of each 179 
gene under a T7lac promoter and a ribosome binding site (RBS). thil was inserted 180 
between the NdeI and XhoI sites of pETDuet-1 to create peT plasmid. atoB was inserted 181 
between the BglII and XhoI sites of pETDuet-1 to form peA plasmid. Plasmid pcHC was 182 
prepared by inserting hbd and crt between the EcoRI and PstI, and NdeI and XhoI sites, 183 
respectively, in pCDFDuet-1 vector. bcd and etfAB fragments were inserted between the 184 
BamHI and SalI and XhoI and PacI sites, respectively, in pCOLADuet-1 to create pkBE. 185 
As an alternative to bcd, acd, encoding an acyl-CoA dehydrogenase from P. putida was 186 
inserted between the SalI and HindIII sites in vector pCOLADuet-1 to create plasmid 187 
pkA.  Additionally, the gene encoding for Streptomyces collinus crotonyl-CoA reductase 188 
(ccr) was synthetically constructed (DNA2.0, Menlo Park, CA) with codon usage 189 
optimized for expression in E. coli.  The synthetic ccr fragment was inserted between the 190 
EcoRI and HindIII sites in vector pCOLADuet-1 to create plasmid pkC. The adhE1 191 
fragment was inserted into pACYCDuet-1 vector between the EcoRI and PstI sites to 192 
create plasmid paA1. The adhE2 fragment was inserted into pACYCDuet-1 vector 193 
between the BamHI and SalI sites to create plasmid paA2. Three plasmids containing 194 
genes encoding enzymes to promote greater glycolytic flux or NADH regeneration were 195 
constructed. Plasmid peAG was created by inserting gapA into the BamHI and SacI sites 196 
of peA. Cloning fdh1 between the NcoI and PstI sites of peA resulted in plasmid peAF. 197 
Together with the T7lac promoter fragment, fdh1 was inserted into peAG between the 198 
SacI and PstI sites to create plasmid peAGF.  199 
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To re-construct the butanol biosynthetic pathway in B. subtilis, the BCS operon 200 
was first ligated between the NheI and SphI sites of pDR111 ((Britton et al., 2002); 201 
donated by Dr. Alan Grossman, MIT) to create pdBCS. pJBN1 and pDRPyr-Kan were 202 
each constructed by ligating the 1.8-kb EcoRI – BamHI fragment containing the hyper-203 
spank promoter, multi-cloning site, and lacI from  pDR111 with EcoRI – BamHI 204 
linearized pDG1664 ((Guerout-Fleury et al., 1996); obtained from the Bacillus Genetic 205 
Stock Center at The Ohio State University) and pPyr-Kan ((Middleton and Hofmeister, 206 
2004); obtained from the Bacillus Genetic Stock Center), respectively.  thil was cloned 207 
into the NheI site of pJBN1 resulting in pjT while adhE2  was ligated between the SalI 208 
and SphI sites of pDRPyr-Kan, yielding ppA2.  Plasmid construction and cloning was 209 
performed using E. coli DH10B.  210 
In all cases, the Expand High Fidelity PCR System (Roche, Basel, Switzerland) or 211 
Phusion High Fidelity DNA Polymerase (Finnzymes, Espoo, Finland) was used for DNA 212 
amplification. Restriction enzymes and T4 DNA ligase were purchased from New 213 
England Biolabs (Ipswich, MA). All positive constructs were identified via restriction 214 
digest and nucleotide sequencing. Plasmids constructed in the present work are listed in 215 
Table 1. 216 
 217 
Strain development and culture conditions  218 
E. coli ED1.0 was obtained by transforming E. coli DH10B with prBCS and 219 
pmTA1 whereas ED2.0 resulted from the transformation of E. coli DH10B with prBCS 220 
and pmTBA1. Positive transformants were isolated on LB plates containing gentamycin 221 
(20 mg/L) and tetracycline (10 mg/L). To create E. coli strain EB1.0, BL21Star(DE3) 222 
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was transformed with plasmids peT, pcHC, pkBE, and paA1. To test the utility of acd 223 
and ccr, EB2.A and EB2.C were created by replacing pkBE in strain EB1.0 with either 224 
pkA or pkC, respectively. Replacement of peT with peA in strain EB1.0 yielded strain 225 
EB3.0.  Strain EB4.0 was created by replacing paA1 with paA2 in EB1.0 to compare the 226 
effect of adhE2 expression with adhE1. In order to explore the possibility of improving 227 
butanol synthesis by increasing intracellular NADH or glycolytic flux towards precursors, 228 
strains EB4.F and EB4.G were created by replacing peA in EB4.0 with peAF and peAG, 229 
respectively. To investigate the effects of both glyceraldehyde 3-phosphate 230 
dehydrogenase and formate dehydrogenase expression on butanol biosynthesis, strain 231 
EB4.GF was created by replacing peA in EB4.0 with peAGF. Cells containing all 232 
compatible plasmids were isolated on LB plates containing ampicillin (30 mg/L), 233 
streptomycin (25 mg/L), kanamycin (25 mg/L), and chloramphenicol (8 mg/L). Deletions 234 
of adhE and ldhA in E. coli BL21Star(DE3) strains were performed according to a 235 
previously reported method (Datsenko and Wanner, 2000). All recombinant strains 236 
developed in this study are listed in Table 2.  237 
Fermentation experiments using ED and EB strains were initiated by culturing the 238 
recombinant strains in 6 mL TB using 15-mL tubes overnight at 37°C, in a shaker 239 
rotating at 225 rpm. The preinoculum was used to seed 150 mL TB medium 240 
supplemented with 5 g/L glucose or glycerol in 250-mL screw-capped flasks, at an initial 241 
optical density at 600 nm (OD600) of 0.05.  Both aerobic and anaerobic culture conditions 242 
were studied.  Anaerobic cultures were first grown under aerobic conditions in sealed 243 
shake flasks to promote biomass production.   With a limited headspace volume, these 244 
closed cultures became naturally depleted of oxygen after 3-5 h (as indicated by the 245 
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addition of 5 mg/L resazurin to the culture medium).  Cultures were incubated at 37°C in 246 
a rotary shaker until OD600 reached 0.8. At this point, 0.1 mM IPTG was added to the 247 
cultures to induce recombinant protein expression. Following induction, cells were 248 
cultivated at 30°C. In all cases, TB medium was supplemented with 20 mg/L gentamycin 249 
and 10 mg/L tetracycline (ED strains), or 30 mg/L ampicillin, 25 mg/L streptomycin, 25 250 
mg/L kanamycin, and 8 mg/L chloramphenicol (EB strains).  The addition of formic acid 251 
to cultures at an initial concentration of 1 g/L was also investigated to promote greater 252 
cofactor regeneration in cultures of EB4.F and EB4.0 (control).  Culture media were 253 
sampled at 24 h intervals for up to 72 h. Samples were centrifuged to pellet cells while 254 
the aqueous supernatant was collected for HPLC analysis.  255 
P. putida S12 was co-transformed with prBCS and pmTA1 to construct PS1.0, or 256 
with prBCS and pmTBA1 to yield PS2.0.  Meanwhile, construction of strains PS1.A and 257 
PS2.A was accomplished by co-transformation of P. putida S12 with prCCS or pmTA1 258 
or pmTBA1, respectively.  Selection of these strains was performed using LB plates 259 
containing 20 mg/L gentamycin and 10 mg/L tetracycline. Butanol production in both PS 260 
strains was performed at 30
o
C in 250 mL shake flasks containing 50 mL TB medium 261 
with 0.5% (wt./vol.) glucose or glycerol. Induction protocols were performed as 262 
described for E. coli, though using 1 mM IPTG. All media were supplemented with 263 
gentamycin (20 mg/L) and tetracycline (10 mg/L). Aerobic conditions were promoted 264 
throughout the study due to the obligately aerobic nature of P. putida.   265 
Competent B. subtilis KS438 cells were sequentially transformed with pdBCS, 266 
pjT, and ppA2 where they were integrated into the chromosome at the amyE, thrC, and 267 
pyrD loci, respectively, via double-crossover homologous recombination. The resultant 268 
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strain, BK1.0, was amyE
_ 
thrC
_
 pyrD
_
. LB plates containing 100 mg/L 269 
spectinomycin,12.5 mg/L lincomycin,0.5 mg/L erythromycin, and 5 mg/L kanamycin 270 
were used for selection of transformants, as appropriate. Butanol fermentation 271 
experiments with BK1.0 were performed as described above for E. coli strains, except 272 
that induction was performed using 1 mM IPTG. Antibiotics were not required for the 273 
maintenance of BK1.0, and thus were not added to the fermentation medium. 274 
 275 
Butanol challenge 276 
50 mL of TB medium was inoculated with preinoculum of E. coli BL21Star(DE3), 277 
P. putida S12, or B. subtilis KS438 to give an initial OD600 of 0.05.  Cultures were 278 
incubated at 30°C while shaking at 250 rpm.  After reaching mid-exponential growth 279 
stage (OD600 ≈ 1.5), challenges were applied by butanol addition to a final concentration 280 
between 0 and 2% (wt./vol.).  Growth and viability were then monitored for 24 hours post 281 
butanol addition through optical density measurements and plate counts, respectively.  282 
Culture samples were diluted in phosphate buffer (pH 7.0) prior to absorbance readings to 283 
yield an average OD600 measurement of 0.5. Culture samples were serially diluted by up 284 
to 10
-7
 in phosphate buffer prior to plating 100 L of each dilution on LB agar and 285 
incubated at 30°C overnight.  Counts were made on all plates yielding a countable 286 
number of distinct colony forming units (CFUs), and expressed as CFU/mL of original 287 
culture.  Error was estimated at one standard deviation of all plates counted for each 288 
sample at each time point (typically 2-3). 289 
 290 
Metabolite analysis 291 
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Solvents and fermentation products were analyzed via HPLC using an Agilent 292 
1100 series instrument equipped with a refractive index detector (RID). Analyte 293 
separation was achieved using an Aminex® HPX-87H anion exchange column (Bio-Rad 294 
Laboratories, Hercules, CA) according to the method of Buday et al. (Buday et al., 1990) 295 
using 5mM H2SO4 as the mobile phase.  External standards provided calibration for titer 296 
determination. 297 
 298 
Results 299 
Construction of butanol-producing E. coli 300 
Butanol synthesis in E. coli was first investigated via polycistronic expression of 301 
the Clostridial genes.  DH10B was transformed with prBCS and pmTA1 (strain ED1.0) 302 
or with prBCS and pmTBA1 (strain ED2.0). Both strains were cultured in TB medium 303 
supplemented with either 0.5% (wt./vol.) glucose or glycerol to assess their ability to 304 
synthesize butanol. Following induction with IPTG, butanol was detected in the culture 305 
broth of both ED1.0 and ED2.0 after about 48 h, but only when the TB medium was 306 
supplemented with glycerol (a more reduced substrate than glucose). Specifically, 307 
butanol synthesis by ED1.0 and ED2.0 reached up to 34 ± 5 mg/L and 33 ± 2 mg/L, 308 
respectively (Figure 2). These results are comparable with earlier efforts to reconstruct 309 
the butanol pathway in E. coli (Atsumi et al., 2008a).  Co-expression of bdhB with adhE1 310 
in strain ED2.0 had no impact on butanol titer. 311 
The establishment of E. coli strains expressing polycistronic constructs provides a 312 
baseline for comparison of productivity with the other heterologous hosts.  However, we 313 
hypothesized that butanol biosynthesis in E. coli could also potentially be improved by 314 
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promoting greater expression of the heterologous Clostridial enzymes. The effects of 315 
different strategies of expressing a heterologous multi-gene biosynthetic pathway on 316 
metabolite production in E. coli have been explored (Hwang et al., 2003).  Specifically, 317 
the polycistronic expression in E. coli of a heterologous pathway was compared with the 318 
simultaneous individual expression of each gene under a promoter and a ribosome 319 
binding site. By using the latter strategy, it was demonstrated that the production of each 320 
recombinant protein in the biosynthetic pathway was improved, translating into increased 321 
production of non-native metabolites.   322 
We tested the effect of individual expression of thil, hbd, crt, bcd, etfAB, and 323 
adhE1 under a T7lac promoter and a ribosome binding site in E. coli EB1.0. Since 324 
butanol production was not improved by expression of bdhB in strain ED2.0 (relative to 325 
ED1.0), bdhB was excluded in the construction of all EB strains. Butanol production after 326 
48 h from EB1.0 was 200 mg/L, which is approximately a five-fold improvement over 327 
the production from strain ED1.0 (Figure 2).  It has repeatedly been demonstrated that 328 
butyryl-CoA dehydrogenase, isolated from either C. acetobutylicum or from recombinant 329 
E. coli, failed to exhibit enzymatic activity in vitro (Atsumi et al., 2008a; Boynton et al., 330 
1996; Hartmanis and Gatenbeck, 1984).  Furthermore, in vivo butyryl-CoA 331 
dehydrogenase activity is also dependent upon the coordinated functional expression of 332 
electron transfer flavoproteins etfA and etfB.  Since the functionality of the butyryl-CoA 333 
dehydrogenase complex could possibly be a rate-limiting step in the butanol synthesis 334 
pathway, we explored the utility of crotonyl-CoA reductase (ccr) derived from 335 
Streptomyces collinus to mediate the conversion of crotonyl-CoA to butyryl-CoA (strain 336 
EB2.C).  ccr has been previously characterized and functionally expressed in E. coli 337 
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(Wallace et al., 1995). As was also noted in previous studies (Atsumi et al., 2008a), we 338 
found this particular substitution to provide inferior results, as butanol production 339 
decreased by 55% compared with strain EB1.0.  The utility of other non-Clostridial 340 
source enzyme homologs also provided unsubstantial improvements to the maximum 341 
butanol titer.  In contrast to previously published work (Atsumi et al., 2008a), the 342 
replacement of thil with atoB from E. coli in strain EB3.0, led to only a modest 343 
improvement in titer, to 220 mg/L butanol.  The replacement of C. acetobutylicum adhE1 344 
in strain EB3.0 with adhE2 led to only 230 mg/L butanol (strain EB4.0; Figure 2).  345 
Although it was reported that adhE2 was the most highly active of these homologs in 346 
alcohologenic cultures of C. acetobutylicum (Fontaine et al., 2002), little difference 347 
between these two homologs was observed in our system. 348 
 349 
Expression of NADH-regenerating and glycolytic flux-enhancing enzymes 350 
 In the butanol biosynthetic pathway, four moles of NADH are consumed (by 351 
oxidation to NAD+) per each mole of butanol produced from acetyl-CoA (Figure 1). In 352 
an effort to improve butanol synthesis by strain EB4.0, we explored the effects of 353 
introducing formate dehydrogenase (fdh1) from Saccharomyces cerevisiae. Yeast 354 
formate dehydrogenase catalyzes the conversion of formate to CO2 while producing one 355 
molecule of NADH (Figure 3). While formate dehydrogenase also exists in E. coli, the 356 
bacterial enzyme catabolizes formate to CO2 and H2 without generation of NAD(P)H. For 357 
this reason, yeast formate dehydrogenase has been exploited in a variety biocatalytic 358 
applications requiring ample NADH molecules for product formation (Berrios-Rivera et 359 
al., 2002; Harris et al., 2000; Kaup et al., 2004; Sanchez et al., 2005; Tishkov and Popov, 360 
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2004). Expression of fdh1 in strain EB4.0 resulted in the generation of strain EB4.F. As 361 
shown in Figure 4, the optimum biobutanol synthesis from strain EB4.F was achieved 362 
after 48 h, similar to that of strain EB4.0. Expression of the yeast fdh1 also resulted in 363 
~74% butanol production improvement over EB4.0, reaching as high as 400 mg/L.  364 
Supplementation of the media with 1 g/L formate, increased maximum butanol titers up 365 
to 520 mg/L with EB4.F, whereas no difference was observed with EB4.0 (Figure 2).  In 366 
E. coli, glyceraldehyde 3-phosphate dehydrogenase mediates the conversion of 367 
glyceraldehyde 3-phosphate to 1,3-diphosphateglycerate in the glycolytic pathway 368 
(Figure 3).  Thus, overexpression of glyceraldehyde 3-phosphate dehydrogenase (gapA) 369 
should promote higher rates of substrate flux through the glycolytic pathway.   370 
Expression of gapA in strain EB4.0 resulted in the generation of strain EB4.G.  Again, 371 
the maximum biobutanol titer from strain EB4.G was achieved after 48 h, and reached a 372 
butanol titer of 580 mg/L, demonstrating that gapA overexpression resulted in ~150% 373 
greater butanol production (relative to EB4.0).  The effects of simultaneously expressing 374 
both gapA and fdh1 was tested in strain EB4.GF. Interestingly, however, butanol 375 
synthesis from strain EB4.GF was only up to 320 mg/L, which was lower than either 376 
EB4.G or EB4.F (Figures 2 and 4). It is possible that simultaneous overexpression of 377 
gapA and fdh1 along with the Clostridial enzymes negatively impacted host fitness. 378 
Characterization of EB4.0 fermentation byproducts revealed that after 48 h, 379 
succinate, lactate, and ethanol constituted the majority of the end-products, at 380 
concentrations of 1400 mg/L, 1700 mg/L, and 1600 mg/L, respectively (Figure 5). 381 
Overexpression of gapA in EB4.G not only resulted in butanol production increase, but 382 
also increased ethanol production by ~18%, likely as a result of increased availability of 383 
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the precursor acetyl-CoA. The expression of fdh1 in strain EB4.F resulted in a ~42% 384 
decrease of formate accumulation compared to EB4.0, down to 250 mg/L.  In addition to 385 
an increase in butanol production, fdh1 co-expression in strain EB4.F also caused ethanol 386 
production to increase by ~12% (Figure 5).  In fact, with the exception of lactate, flux 387 
through each of the natural NADH-consuming fermentative pathways of E. coli (i.e., 388 
ethanol and succinate) was enhanced when fdh1 was co-expressed.  Deletions of adhE 389 
and/or ldhA did not improve carbon flux and/or NADH availability, instead resulting in a 390 
decrease in growth rate and butanol production in all strains tested (data not shown).   391 
 392 
Engineering P. putida and B. subtilis for Butanol Biosynthesis 393 
 The previously observed sensitivity of E. coli to elevated butanol concentrations 394 
motivated the engineering of alternative butanol production platforms in more tolerant, 395 
yet still well-characterized, strains.  P. putida strains PS1.0 and PS2.0 were obtained by 396 
co-transformation with either prBCS and pmTA1 or prBCS and pmTBA1, respectively.  397 
These strains were cultured in TB medium supplemented with 0.5% glucose or glycerol, 398 
however only aerobic conditions could be studied as P. putida is an obligately aerobic 399 
organism. As seen in Table 3, PS1.0 and PS2.0 achieved initial butanol titers of 44 ± 6 400 
and 50 ± 6 mg/L with glucose, respectively, and 122 ± 12 and 112 ± 14 mg/L with 401 
glycerol, respectively. As with E. coli, butanol production was highest when using the 402 
more reduced substrate, glycerol. In this case butanol production by PS1.0 and PS2.0 was 403 
~260% (3.6-fold) and ~240% (3.4-fold) greater than their respective E. coli counterparts 404 
(ED1.0 and ED2.0, respectively; Figure 2). Again, the co-expression of bdhB was found 405 
to yield an insignificant effect on butanol production.  The capacity to produce such 406 
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butanol titers under aerobic conditions in engineered strains of P. putida is of particular 407 
phenomenological interest because it questions the longstanding and generally accepted 408 
position that the bcd-etfAB complex of C. acetobutylicum is inactive in the presence of 409 
oxygen.  For instance, a recent report has shown that the activity of C. kluyveri butyryl-410 
CoA dehydrogenase could in fact be demonstrated in vitro, but only when the enzymes 411 
were prepared under a strict oxygen-free environment, and in the presence of FAD (Li et 412 
al., 2008).  The presence of an acyl-CoA dehydrogenase (acd) in P. putida KT2440 with 413 
catalytic activity on crotonyl-CoA/butyryl-CoA under aerobic conditions has recently 414 
been reported (McMahon et al., 2005).  To determine if the heterologous bcd-etfAB 415 
complex was responsible for providing butyryl-CoA dehydrogenase activity in butanol-416 
producing strains of P. putida, or whether this activity was perhaps alternatively derived 417 
from an endogenous acd or other homologous protein, we constructed a bcd- and etfB-418 
deficient derivative of the BCS operon which was expressed from pRK415 as prCCS 419 
(strains PS1.A, PS2.A).  After 72 h of culture, no butanol production was detected in the 420 
culture medium with either strain PS1.A or PS2.A (Figure 2).  In a complementary 421 
experiment, expression of acd from P. putida instead of bcd-etfAB in E. coli (strain 422 
EB2.A) abolished butanol biosynthesis.  These two experiments provide strong evidence 423 
that the bcd-etfAB complex is in fact functional under aerobic conditions. 424 
 Reconstruction of the butanol biosynthetic pathway in B. subtilis was achieved by 425 
serial transformation with each of plasmids pdBCS, pjT, and ppA2, producing strain 426 
BK1.0. In this case, the expression of the polycistronic BCS operon was performed using 427 
a single, strong (hyper-spank) promoter. Although it had demonstrated no distinct 428 
benefits in strain EB4.0, adhE2 was chosen among aldehyde/alcohol dehydrogenase 429 
  20 
homologs based on its previously demonstrated activity in C. acetobutylicum (Fontaine et 430 
al., 2002). bdhB, on the other hand, was excluded from this design because it 431 
demonstrated no beneficial effects in either E. coli or P. putida. BK1.0 was cultured in 432 
TB medium supplemented with 0.5% glucose or glycerol, under both aerobic and 433 
anaerobic conditions.  As seen in Table 3, no butanol production was detected under 434 
aerobic conditions.  However, after 72 h under anaerobic conditions, BK1.0 produced a 435 
maximum of 23 ± 4 and 24 ± 4 mg/L butanol with glucose and glycerol supplementation, 436 
respectively. Therefore, despite sharing greater phylogentic similarity with Clostridium 437 
than both E. coli and P. putida, expression of Clostridial genes in B. subtilis did not 438 
improve the apparent activity of this heterologous pathway.  439 
 440 
Assessing the butanol tolerance of E. coli, P. putida, and B. subtilis  441 
To assess the production potential of the various butanol-producing strains 442 
constructed, we studied the inhibitory effects of butanol on the dynamic and steady-state 443 
growth phenotypes of E. coli, P. putida, and B. subtilis.  As seen in Figure 6, the addition 444 
of at least 0.5% (wt./vol.) butanol to cultures of E. coli and P. putida, or at least 1.0% 445 
(wt./vol.) butanol to B. subtilis cultures, resulted in rapid and markedly negative effects 446 
on both the growth rate and biomass yield.  Addition of 2.0% (wt./vol.) butanol was 447 
completely lethal to all cultures tested within about 30 min. The addition of butanol at 448 
0.5% (wt./vol.) or higher to E. coli cultures caused a rapid decrease (within 30 minutes) 449 
in growth rate and OD600 relative to the control culture.  Viability, however, was only 450 
observed to decrease significantly in the presence of at least 1.0% (wt./vol.) butanol over 451 
the same time period.  Adaptation to the solvent stresses was observed for E. coli cultures 452 
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with between 0.5 and 0.75% (wt./vol.) butanol, as shown by increases in viable cell 453 
concentration after approximately 100 minutes.  P. putida and B. subtilis also 454 
demonstrated similar behaviors, though with respect to different characteristic butanol 455 
concentrations. A pseudo-steady state at which there was nearly no net change in OD600 456 
or culture viability relative to that at the time of butanol addition occurred after addition 457 
of 0.75, 1.0, and 1.25% (wt./vol.) butanol to cultures of P. putida, E. coli, and B. subtilis, 458 
respectively. Above these respective concentrations, however, decreases in both 459 
measurements were observed.   460 
 461 
Discussion 462 
Although the bacterium E. coli is a well-characterized microorganism from both a 463 
genetic and metabolic perspective and boasts a vast availability of genetic tools for its 464 
engineering, the susceptibility of E. coli to high butanol concentrations complicates its 465 
development as a butanol production strain.  Nevertheless, we selected E. coli as our first 466 
prototype strain for the development of an alternative butanol producer in order to 467 
provide a baseline for comparison with our other non-native hosts, as well as with other 468 
works recently reported in the literature. Enhanced expression of the butanol pathway 469 
genes was achieved via replacement of the polycistronic BCS operon to provide 470 
expression using individual promoter-RBS sequences and resulted in nearly a six-fold 471 
improvement in product titer.  It has recently been shown that the expression levels of 472 
several butanol biosynthetic genes were significantly higher in a butanol hyper-producing 473 
mutant of C. beijerinckii than that of the wild-type strain (Chen and Blaschek, 1999).  474 
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Recruitment of enzymes with homologous function from alternative genetic sources had 475 
limited results, which is consistent with previous reports (Atsumi et al., 2008a).   476 
Co-expression of fdh1 from yeast to provide cofactor regeneration in E. coli 477 
resulted in further improvement of butanol titers up to 400 mg/L in shake flask cultures.  478 
However, it was expected that this strategy could provide only limited improvements as 479 
endogenous formate levels were quite low (Figure 5).  By provision of exogenous 480 
formate, flux through the butanol pathway was increased, presumably as a result of 481 
elevated rates of NADH regeneration.  Although supplementation of the culture media 482 
with formate does not represent a sustainable practice for butanol fermentations, it does 483 
suggest that an insufficient supply of intracellular NADH may limit the activity of the 484 
heterologous butanol pathway in engineered E. coli.  Meanwhile, overexpression of gapA 485 
from E. coli to promote greater glycolytic flux and increase the acetyl-CoA pool resulted 486 
in final butanol titers of 580 mg/L.  This titer is comparable to the maximum reported by 487 
Atsumi et al. (2008) and did not require the deletion of endogenous genes.  As shown in 488 
Figure 5, the co-expression of both gapA and fdh1 resulted in a notable increase in 489 
succinate production, a phenomenon that can be explained two-fold. Firstly, the 490 
overexpression of gapA increases the flux through phosphoenolpyruvate carboxylase 491 
towards the synthesis of oxaloacetate, a precursor of succinate (Causey et al., 2004).  492 
Since the overexpression of gapA was also likely to result in increased accumulation of 493 
acetyl-CoA (as indicated by observed increases in ethanol accumulation; Figure 5), a 494 
substrate of malate synthase, this would ultimately lead to increased production of malate 495 
and succinate.  Secondly, the NADH regenerated via fdh1 co-expression can also serve as 496 
an electron donor for both malate dehydrogenase and fumarate reductase (Causey et al., 497 
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2004), two enzymes involved in succinate biosynthesis.  Overall, the elevation of 498 
fermentative byproducts reflects an increase in the intracellular NADH/NAD+ ratio (de 499 
Graef et al., 1999). 500 
One means of reducing carbon flux towards fermentative byproducts and 501 
affecting the co-factor balance could involve deletions of adhE and ldhA, the primary 502 
enzymes responsible for the production of ethanol and lactate, respectively.  In this study, 503 
deletion of either or both of these genes led to decreases in butanol productivity.  These 504 
two deletions were previously found to improve butanol titers from glucose in engineered 505 
E. coli when combined with additional gene deletions (Atsumi et al., 2008a).  Similarly, 506 
glucose flux to pyruvate was significantly enhanced when adhE and ldhA deletions were 507 
included among several genetic modifications (Causey et al., 2004).  Thus, it may be that 508 
additional mutations (e.g., frd deletion) are required to observe the positive effect 509 
associated with adhE and/or ldhA deletions.  1,2-Propanediol productivity was previously 510 
improved in an ldh mutant of E. coli, but only with glucose as a substrate (Berrios-Rivera 511 
et al., 2003).  Considering this observation, our use of the more reduced glycerol as a 512 
substrate may also have impacted these results.  Finally, it should be noted that our 513 
experiments were performed with BL21(DE3), a B strain, while each of the previous 514 
studies utilized K-12 strains.  The reported differences in metabolic activity between 515 
these strains (Phue et al., 2005; Phue and Shiloach, 2004) may have also contributed to 516 
the observed lack of effect of adhE and ldhA in this study.  517 
Ultimately, the availability of excess reducing equivalents and/or enhanced 518 
metabolite flux could only provide limited improvements towards butanol production due 519 
likely to the slow enzyme kinetics of the engineered butanol pathway.  Our results 520 
  24 
support those of previous studies (Li et al., 2008) in suggesting that the slow turn-over 521 
rate of the Clostridium butyryl-CoA dehydrogenase complex likely limited the capacity 522 
of the engineered butanol pathway.  In C. kluyveri, activity of the enzyme encoded by the 523 
bcd-etf complex has recently been found to be rate-limiting in butyraldehyde synthesis. It 524 
was postulated that the slow kinetics demonstrated by this enzyme complex may result 525 
from complexities associated with the endergonic reduction of ferredoxin with NADH 526 
and the exergonic reduction of crotonyl-CoA with NADH (Li et al., 2008).  In vitro 527 
activity of bcd-etfAB could not be detected from any of the strains constructed in this 528 
study.  Previous works have also highlighted the difficulty associated with confirming the 529 
in vitro activity of bcd-etfAB as expressed in recombinant E. coli (Boynton et al., 1996) 530 
or from C. acetobutylicum itself (Hartmanis and Gatenbeck, 1984), often citing the 531 
possible sensitivity of this enzyme complex to oxygen.  Although product titers were 532 
quite low, functional expression of the butanol pathway has previously been achieved in 533 
E. coli under aerobic conditions, despite the inability to assay bcd-etfAB activity in vitro 534 
(Atsumi et al., 2008a).  Compared to that work, butanol titers obtained under aerobic 535 
conditions in this study were improved by nearly 15-fold using P. putida as the host 536 
organism (122 mg/L vs. ~8 mg/L).  If C. acetobutylicum bcd-etfAB did in fact suffer from 537 
decreased activity in the presence of oxygen, then the functional pathway construction in 538 
P. putida under aerobic conditions could have been aided by the activity of native 539 
isozymes catalyzing the same reaction of crotonyl-CoA to butyryl-CoA.  However, as we 540 
have demonstrated, butanol production was dependent upon the presence of bcd-etfAB 541 
and expression of acd did not complement butanol biosynthesis in our engineered strains 542 
of E. coli, indicating that background enzymatic activity alone was insufficient for 543 
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catalyzing this reaction under the culture conditions studied.  These results support the 544 
notion that it may be the method of analysis, and not the sensitivity of this enzyme to 545 
dissolved oxygen, that is in fact responsible for the inability to assay this step of the 546 
butanol biosynthetic pathway.   547 
The susceptibility of E. coli to the toxic effects of butanol prompted our interest in 548 
engineering of butanol-producing strains of both P. putida and B. subtilis.  In this case, 549 
we found that B. subtilis displayed elevated butanol tolerance, when compared with P. 550 
putida and E. coli.  The polycistronic expression of C. acetobutylicum genes in B. subtilis 551 
resulted in butanol synthesis at similar titers to engineered E. coli ED strains. This result 552 
represents a step toward the generation of an alternative butanol production platform with 553 
improved solvent tolerant characteristics.  As with E. coli, we anticipate the butanol titers 554 
from P. putida and B. subtilis could now be substantially improved through host-specific 555 
strategies.  Significant improvements of butanol biosynthesis were achieved in E. coli as 556 
a result of an improved gene expression strategy that involved individual promoter and 557 
RBS sequences associated with each pathway enzyme, as well as through the 558 
overexpression of enzymes to increase glycolytic flux or facilitate cofactor regeneration.  559 
Furthermore, as has been previously demonstrated in E. coli, in vivo evolution of 560 
heterologous pathway elements can also lead to improved productivities in a non-native 561 
host (Meynial Salles et al., 2007).  In P. putida strains, improved expression could also be 562 
achieved through the use of a Pseudomonas-derived promoter as opposed to the E. coli-563 
derived lac promoter employed in this study.  Furthermore, the lack of extensive natural 564 
product biosynthesis in Pseudomonas sp. also reduces the potential for molecular cross-565 
talk, contamination, and competition with native pathways in heterologous production 566 
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efforts (Zhang et al., 2008a).  The functional expression of the butanol biosynthesis 567 
pathway in P. putida and B. subtilis further illustrates the potential of these under-utilized, 568 
yet industrially relevant, strains as production hosts. 569 
In addition to n-butanol, E. coli  has also recently been engineered for the 570 
production of other potential biofuels consisting of higher alcohols such as iso-butanol 571 
(Atsumi et al., 2008b), 2-methyl-1-butanol (Cann and Liao, 2008), 3-methyl-1-butanol 572 
(Connor and Liao, 2008), as well as n-pentanol, 3-methyl-1-pentanol, and n-hexanol 573 
(Zhang et al., 2008b).  Despite their favorable thermodynamic properties, it has been 574 
thoroughly demonstrated that the cytotoxicity of an alcohol is elevated with an increasing 575 
carbon chain length (Heipieper and Debont, 1994; Osborne et al., 1990a; Vermue et al., 576 
1993).  Thus, the problems associated with the cytotoxicity of both conventional and 577 
second-generation biofuels will remain apparent, and represent an increasing requirement 578 
for robust biocatalyst platforms. 579 
The pseudo-steady state behavior observed with respect to butanol inhibition 580 
represents a critical condition above which growth and viability became most severely 581 
inhibited, and below which cultures remained prosperous.  This state was found to be a 582 
distinguishing feature of each organism, however the characteristic range of critical 583 
butanol concentrations was found to be seemingly narrow (0.75 to 1.25%).  This finding 584 
is consistent with a previous study which found that a selection of Gram-positive and 585 
Gram-negative bacteria, including Arthrobacter, Norcadia, Acinetobacter, and 586 
Pseudomonas sp., each displayed very similar tolerance to a series of n-alkanol solvents, 587 
including butanol (Vermue et al., 1993).  More recently, the inhibitory effects of butanol 588 
on the growth of 24 different microorganisms, including several species of bacteria and 589 
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yeast, was investigated (Knoshaug and Zhang, 2008).  Although Pseudomonas and 590 
Bacillus were excluded from that study, those findings also confirmed the existence of a 591 
narrow range of toxic thresholds (between 1 and 2% (wt./vol.)) for most strains.  Two 592 
strains of Lactobacillus, however, were found to capable of maintaining growth in 593 
butanol concentrations as high as 3%.  Meanwhile, additional strains of Lactobacillus and 594 
the phylogenetically related species Enterococcus have also been reported as capable of 595 
tolerating up to 2.5% (wt./vol.) butanol on solid media (Bramucci et al., 2007; Bramucci 596 
et al., 2008).  Interspecies similarity of butanol toxic threshold concentrations is likely a 597 
result of high homology between the cytoplasmic membrane structures of the studied 598 
organisms particularly when it is considered that the inhibitory mechanism involves 599 
membrane accumulation leading to structural distortion.  Although the specific strains of 600 
P. putida investigated here showed a relatively low sensitivity threshold to butanol, 601 
evolved strains of P. putida that can grow in the presence of up to 6% (wt./vol.) butanol 602 
have recently been isolated (Ruhl et al., 2009).  Since the P. putida pathway 603 
reconstruction strategy outlined here would be compatible with these novel organisms, 604 
these hosts would make excellent candidates as alternative butanol production strains. 605 
Solvent tolerance can be further engineered, for example, as it was in Clostridium 606 
through the overexpression of stress (heat shock) proteins (Tomas et al., 2003). Other 607 
widely employed approaches towards enhancing the desired phenotypes of industrial 608 
biocatalysts most frequently rely upon mutagenic techniques.  However, the identification 609 
of enhanced phenotypes obtained via stochastic mutation procedures typically requires 610 
laborious screening and selection processes.  Such techniques can also elicit an 611 
unforeseen impact on host fitness and decrease its overall industrial utility (Bonomo et al., 612 
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2006).  Furthermore, since complex phenotypes such as solvent tolerance are not 613 
monogenic (Alper et al., 2006), several distinct mutation events would be required to be 614 
performed in highly specific combinations.  In contrast, broader mechanisms utilizing 615 
global transcription machinery engineering (gTME) have been successfully demonstrated 616 
for the elevation of ethanol tolerance in yeast (Alper et al., 2006) and E. coli (Alper and 617 
Stephanopoulos, 2007).  The use of naturally solvent tolerant microorganisms as host 618 
productions strains does not negate the relevance or applicability of previously developed 619 
molecular techniques.  Rather, the selection of an appropriate host as a starting point is a 620 
critical challenge for the for the engineering of solvent tolerant phenotypes via such 621 
combinatorial procedures (Fischer et al., 2008).  The outlined approach thus remains 622 
compatible with such emerging techniques while providing an elevated baseline of 623 
natural solvent tolerance from which next generation butanol producing microorganisms 624 
can be engineered. 625 
 626 
Conclusion 627 
Although Clostridia are the traditional organisms employed in biobutanol 628 
production, a significant and growing amount of research is centered on the engineering 629 
of more robust strains capable of elevated production. Because systematic approaches to 630 
improve butanol production traits of Clostridium are currently impeded by a lack of 631 
characterization and genetic tools, this work has focused on the generation of a variety of 632 
tractable strains which allow for versatile manipulations with the objective of improving 633 
butanol fermentation.  Functional butanol pathways were successfully constructed in E. 634 
coli, P. putida, and B. subtilis.  Experimental titers were highest in E. coli and benefited 635 
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from optimized expression strategies.  Although B. subtilis displayed the most solvent 636 
tolerant phenotype among the studied strains, thus providing it with the greatest 637 
production potential, it was found to be the poorest producing strain.  Preliminary titers 638 
obtained in engineered strains of P. putida were superior to those obtained by E. coli 639 
under aerobic conditions in previous studies, and titers from both P. putida and B. subtilis 640 
were notably better than those recently achieved in yeast (Steen et al., 2008). Although 641 
the specific strain studied displayed sensitivity to butanol, with concurrent work on the 642 
evolution of more solvent tolerant strains of P. putida, pseudomonads may constitute an 643 
effective butanol production host in the future.  Overall, this work has demonstrated the 644 
engineering of butanol biosynthesis in heterologous, solvent-tolerant microorganisms.    645 
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Table 1. Plasmids used or constructed in this study. 
 
Plasmid Description Source 
pRK415 Tet
r
, lac (Keen et al., 1988b) 
pMMB206 Cm
r
, lacI, taclac (Morales et al., 1991) 
pMMB206G Gm
r
, lacI, taclac This study 
pETDuet-1 Ap
r
, lacI, T7lac Novagen 
pCDFDuet-1 Sm
r
, lacI, T7lac Novagen 
pCOLADuet-1 Km
r
, lacI, T7lac Novagen 
pACYCDuet-1 Cm
r
, lacI, T7lac Novagen 
pDG1664 Ap
r
 (E. coli), Em
r
 (B. subtilis), thrC locus (Guerout-Fleury et 
al., 1996) 
pPyr-Kan Ap
r
 Km
r
 (E. coli), Km
r
 (B. subtilis), pyrD locus (Middleton and 
Hofmeister, 2004) 
pDR111 Ap
r
 (E. coli), Sp
r
 (B. subtilis), lac I, hyper-spank, amyE locus (Britton et al., 2002) 
pJBN1 Ap
r
 (E. coli), Em
r
 (B. subtilis), lac I, hyper-spank, thrC locus This study 
pDRPyr-Kan Ap
r
 Km
r
 (E. coli), Km
r
 (B. subtilis), lac I, hyper-spank, pyrD locus This study 
prBCS Tet
r
, lac: BCS (crt, bcd, etfAB, hbd) This study 
prCCS Tet
r
, lac: BCS (crt, etfA, hbd) This study 
pmTA1 Gm
r
, lacI, taclac: thil, adhE1  This study 
pmTBA1 Gm
r
, lacI, taclac: thil,  bdhB, adhE1 This study 
peT Ap
r
, lacI, T7lac: thil This study 
peA Ap
r
, lacI, T7lac: atoB  This study 
pcHC Sm
r
, lacI, T7lac: hbd, T7lac: crt  This study 
pkBE Km
r
, lacI, T7lac: bcd, T7lac: etfAB  This study 
pkA Km
r
, lacI, T7lac: acd This study 
pkC Km
r
, lacI, T7lac: Synccr This study 
paA1 Cm
r
, lacI, T7lac: adhE1 This study 
paA2 Cm
r
, lacI, T7lac: adhE2 This study 
peAF Ap
r
, lacI, T7lac: atoB, T7lac: fdh1  This study 
peAG Ap
r
, lacI, T7lac: atoB, T7lac: gapA This study 
peAGF Ap
r
, lacI, T7lac: atoB, T7lac: gapA, T7lac: fdh1 This study 
pdBCS Ap
r
 (E. coli), Sp
r
 (B. subtilis), lac I, hyper-spank: BCS This study 
pjT Ap
r
 (E. coli), Em
r
 (B. subtilis), lac I, hyper-spank: thil This study 
ppA2 Ap
r
 Km
r
 (E. coli), Km
r
 (B. subtilis), lac I, hyper-spank: adhE2 This study 
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Table 2. Strains of E. coli, P. putida, and B. subtilis engineered for this study. 
 
Strain Genotype or plasmid inserted Source 
E. coli strains   
DH10B 
F
-
 mcrA (mrr-hsdRMS-mcrBC) 80dlacZM15 
lacX74 deoR recA1 araD139 (ara leu)7697 galU 
galK
 
rpsL endA1 nupG 
Invitrogen 
  ED1.0 prBCS, pmTA1 This study 
  ED2.0 prBCS, pmTBA1 This study 
BL21Star(DE3) F
-
 ompT hsdSB(rB
-
 mB
-
) gal dcm (DE3) Invitrogen 
  EB1.0 peT, pcHC, pkBE, paA1 This study 
  EB2.A peT, pcHC, pkA, paA1 This study 
  EB2.C peT, pcHC, pkC, paA1 This study 
  EB3.0 peA, pcHC, pkBE, paA1 This study 
  EB4.0 peA, pcHC, pkBE, paA2 This study 
  EB4.F peAF, pcHC, pkBE, paA2 This study 
  EB4.G peAG, pcHC, pkBE, paA2 This study 
  EB4.GF peAGF, pcHC, pkBE, paA2 This study 
   
P. putida strains   
S12 Wild type ATCC 
  PS1.0 prBCS, pmTA1 This study 
  PS1.A prCCS, pmTA1 This study 
  PS2.0 prBCS, pmTBA1 This study 
  PS2.A prCCS, pmTBA1 This study 
   
B. subtilis strains   
KS438 spoIIAI SP^o 
(Errington and 
Mandelstam, 1983) 
  BK1.0
 
amyE::pdBCS, thrC ::pjT, pyrD::ppA2 This study 
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Table 3. Comparing butanol production (mg/L) by engineered strains of P. putida S12 (PS) and B. subtilis KS438 
(BK) in different media, and under different growth conditions. 
 
 Aerobic, TB media with 0.5% (wt./vol.) Anaerobic, TB media with 0.5% (wt./vol.) 
P. putida strains Glucose Glycerol Glucose Glycerol 
PS1.0 44 ± 6 122 ± 12 n.a. 
1 
n.a. 
1
 
PS2.0 50 ± 6 112 ± 14 n.a. 
1
 n.a. 
1
 
     
B. subtilis strains     
BK1.0 n.d. n.d. 23 ± 4 24 ± 4 
 
n.a., not applicable 
n.d., not detected 
1
 note that P. putida is obligately aerobic 
843 
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FIGURE CAPTIONS 844 
 845 
Figure 1. The Acetone-Butanol-Ethanol (ABE) fermentation pathway of C. 846 
acetobutylicum. Enzymatic steps used to reconstruct the biobutanol pathway are shown in 847 
bold.  Relevant C. acetobutylicum genes are also indicated, while those genes encoding 848 
enzymes of homologous function from alternative genetic sources are shown in 849 
parentheses. 850 
 851 
Figure 2.  A comparison of the maximum butanol titers for all strains constructed in this 852 
study, including those which utilize polycistronic gene expression (A) or individual gene 853 
expression (B).  All strains cultured in TB media with 0.5% (wt./vol.) glycerol with 854 
(diagonal) or without (hashed and gray) supplementation with 1 g/L formate.  Error bars 855 
shown at one standard deviation. 856 
 857 
Figure 3. Engineering the central metabolic pathway of E. coli to increase glycolytic flux 858 
and promote NADH regeneration in support of butanol synthesis. 859 
 860 
Figure 4. Effects of co-expression of gapA and/or fdh1 on butanol production by strains 861 
EB4.0 (control, solid squares), EB4.G (gapA
+
, open circles), EB4.F (fdh1
+
, solid circles), 862 
and EB4.GF (gapA
+
 fdh1
+
, half-filled circles) as a function of time.  Error bars shown at 863 
one standard deviation. 864 
 865 
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Figure 5. Metabolite byproduct formation by strains EB4.0 (black), EB4.G (dark gray), 866 
EB4.F (light gray), and EB4.GF (white).  Error bars shown at one standard deviation. 867 
 868 
Figure 6.  Effect of butanol addition on growing cultures of E. coli BL21 (DE3), P. 869 
putida S12, and B. subtilis KS438 as determined by viable cell concentration and optical 870 
density.  Butanol was added to mid-exponential stage cultures at final aqueous 871 
concentration (% wt./vol.) of: 0 (solid diamonds), 0.25 (open squares), 0.5 (solid 872 
triangles), 0.75 (open circles), 1.0 (solid circles), 1.25 (open triangles), 1.5 (solid squares), 873 
and 2.0 (open diamonds).  Note that series data were excluded when zero viable cells 874 
were obtained, as was observed after 1.5 and/or 2% (wt./vol.) butanol addition.  Error 875 
bars shown at one standard deviation. 876 
 877 
 878 
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Figure 1. The Acetone-Butanol-Ethanol (ABE) fermentation pathway of C. acetobutylicum. Enzymatic 
steps used to reconstruct the biobutanol pathway are shown in bold.  Relevant C. acetobutylicum genes 
are also indicated, while those genes encoding enzymes of homologous function from alternative genetic 
sources are shown in parentheses. 
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Figure 3. Engineering the central metabolic pathway of E. coli to increase glycolytic flux 
and promote NADH regeneration in support of butanol synthesis. 
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Figure 4. Effects of co-expression of gapA and/or fdh1 on butanol production by strains 
EB4.0 (control, solid squares), EB4.G (gapA
+
, open circles), EB4.F (fdh1
+
, solid circles), 
and EB4.GF (gapA
+
 fdh1
+
, half-filled circles) as a function of time.  Error bars shown at 
one standard deviation. 
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Figure 5. Metabolite byproduct formation by strains EB4.0 (black), EB4.G (dark gray), 
EB4.F (light gray), and EB4.GF (white).  Error bars shown at one standard deviation. 
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